ScreenerHero

PRGO Perrigo Company plc

NYSE · US · Healthcare · Drug Manufacturers - Specialty & Generic · perrigo.com
14.55USD+3.93%Mkt Cap: 2.02B $P/E: —

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$66.23BUSDP/E 25.7
TAK
Takeda Pharmaceutical Company Limited
$58.68BUSD
TEVA
Teva Pharmaceutical Industries Limited
$45.70BUSDP/E 65.3
GALD
Galderma Group AG
$43.27BUSDP/E 56.1
HLN
Haleon plc
$39.67BUSDP/E 18.4
SDZ
Sandoz Group AG
$34.93BUSDP/E 60.5
HLN
Haleon plc
$32.73BUSDP/E 19.0
ZOE
Zoetis Inc.
$28.56BUSDP/E 12.2
ZTS
Zoetis Inc.
$29.57BUSDP/E 11.8
UTHR
United Therapeutics Corporation
$23.38BUSDP/E 19.5
VTRS
Viatris Inc.
$20.09BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.43BUSDP/E 112.9
NBIX
Neurocrine Biosciences, Inc.
$14.58BUSDP/E 21.0
IPN
Ipsen S.A.
$12.99BUSDP/E 23.5
ELAN
Elanco Animal Health Incorporated
$11.17BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.22BUSDP/E 27.9
KRK
Krka, d. d.
$8.66BUSDP/E 19.3
ALKS
Alkermes plc
$6.95BUSDP/E 109.1
HIMS
Hims & Hers Health, Inc.
$6.89BUSD
AMRX
Amneal Pharmaceuticals, Inc.
$6.84BUSDP/E 40.1

Key Statistics

Company
Market Cap2.02B USD
Enterprise Value5.02B USD
Revenue (TTM)4.14B USD
Gross Profit1.49B USD
Net Income (TTM)-1.43B USD
Revenue/Share29.83 USD
Last Price14.55 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees8.1K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)5.84
PEG1.14
EV/EBITDA8.15
EV/Revenue1.21
P/S0.47
P/B0.77
EPS (TTM)-11.91
EPS (Forward)2.40
52W Range
9.23041% of range22.21
52W High22.21 USD
52W Low9.230 USD
Profitability
Gross Margin35.14%
Oper. Margin3.84%
EBITDA Margin14.85%
Profit Margin-33.51%
ROE-48.56%
ROA-16.70%
Growth
Revenue Growth-3.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF238.50M USD
CapEx (TTM)93.40M USD
FCF Margin10.55%
FCF Yield21.65%
Net Debt3.08B USD
Net Debt/EBITDA5.00
Balance Sheet
Debt/Equity1.24
Current Ratio2.32
Quick Ratio1.09
Book Value/Sh18.14 USD
Cash/Share2.88 USD
Dividends
Fwd Div Rate1.16 USD
Trail. Div Rate1.16 USD
Div. Yield8.03%
5Y Avg Yield3.70%
Payout Ratio1348.75%
Ex-Div DateAug 28, 2026
Pay DateSep 15, 2026
Splits
Last Split2:1
Split DateAug 26, 1993
Analyst Consensus
Rating—
Target (Mean)16.50 USD
Upside (mean)+13.4%
Target Range14.00 USD – 20.00 USD
14.00+13.4% to mean20.00
# Analysts4
Ownership
Shares Out.138.77M
Float138.07M
Insiders0.39%
Institutions115.43%
Short Interest
Short Ratio9.2d
Short % Float25.02%
Short % Out.16.31%
Shares Short22.64M
Short (prev mo.)22.18M
Technical
SMA 5013.44 (+8.2%)
SMA 20012.30 (+18.3%)
Beta0.69
S&P 52W Chg15.78%
Avg Vol (30d)2.69M
Avg Vol (10d)3.05M
Technical Indicators
RSI (14)54.6
MACD0.2274
MACD Signal0.2979
MACD Hist.-0.0705
BB Upper15.36 USD
BB Middle14.18 USD
BB Lower13.00 USD
BB Width16.65%
ATR (14)0.6432 USD
Vol Ratio (20d)0.68x